The Valley Desk

NCT03153111 · Interventional trial

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Overall registry status Completed

Phase 2

Conditions Heart Failure With Preserved Ejection Fraction

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov